Robotic Rehabilitation and Dual-Task Exercises in Hemiplegic Patients
Launched by USKUDAR UNIVERSITY · Nov 27, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective a new type of rehabilitation is for patients who have had a stroke and now experience weakness on one side of their body, known as hemiplegia. The study is testing a combination of robotic exercises and activities that require doing two tasks at once, which may help improve both movement and cognitive skills.
To be eligible for this trial, participants should be between 45 and 65 years old and have had a stroke causing hemiplegia between 3 months to 1 year ago. They should also be able to voluntarily participate in rehabilitation and have a certain level of motor function loss. However, those with severe joint problems, other neurological conditions, or recent strokes won't be able to join. If you or someone you know is interested in participating, they can expect to engage in activities that aim to improve their movement and thinking skills in a supportive environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of post-stroke hemiplegia (hemiplegia onset must be between 3 months and 1 year).
- • Age range: 30-60 years.
- • Voluntariness to participate in rehabilitation.
- • Patients with a motor function loss of 30-70% according to Fugl-Meyer Motor Assessment results.
- • Literacy
- Exclusion Criteria:
- • History of active psychiatric disease.
- • Severe joint deformities or other neurological diseases.
- • Having had a recent stroke during rehabilitation.
About Uskudar University
Uskudar University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing research and innovation in the fields of psychology, health sciences, and social sciences. As a clinical trial sponsor, Uskudar University leverages its extensive network of experts and cutting-edge facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the global body of scientific knowledge. The university emphasizes ethical research practices and collaboration with healthcare professionals, ensuring that its trials are designed to adhere to the highest standards of safety and efficacy. Through its clinical research initiatives, Uskudar University seeks to foster advancements in medical science and enhance the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Sancaktepe, Turkey
Patients applied
Trial Officials
Kübra UZUN
Study Chair
Uskudar University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported